MAPT and frontotemporal dementia: JNPL3 animals, carrying the tau mutation responsible for frontotemporal dementia in humans, were treated with weekly intraperitoneal injections of distinct p-tau antibodies: CP13 (pSer202), RZ3 (pThr231) and PG5 (pSer409).